Beverly Tang , PhD

Consultant


, CA

Lucile Packard Biodesign Innovation Fellow, 2007-08 Beverly Tang is currently consulting for Stryker Neurovascular (Fremont, CA) on a legacy Concentric Medical product for acute ischemic stroke treatment (Concentric was acquired by Stryker in 2011). Previously, she was the Principal Engineer/Technical Project Leader for SeptRx, Inc., a small cardiovascular device start-up company focused on creating innovative treatments for structural heart defects such as patent foramen ovale (PFO). As one of only two employees, her responsibilities included product development, vendor management, clinical trial design, physician training (and "everything else" in between!).

Bev graduated from Stanford University with a B.S. in Materials Science and Engineering and a minor in Chemistry. She then completed an internship at IBM Almaden under Stanford's Center on Polymer Interfaces and Macromolecular Assemblies (CPIMA) and worked on building polymers for organic light emitting diodes. Bev went on to finish her M.S. in Materials Science and Engineering and Ph.D. in Mechanical Engineering, both from Stanford. Her doctoral research focused on using a combined MRI and computational fluid dynamics approach to study the role of blood flow conditions in the initiation, progression, and prevention of diseases such as atherosclerosis and pulmonary arterial hypertension. She was a recipient of the Benchmark Capital Congenital Cardiovascular Bioengineering Fellowship.

Bev was a Stanford Biodesign Innovation Fellow during the 2007-2008 Fellowship year. Her team focused on innovating in the area of Anesthesia and worked on a number of technologies in Obstetrics and Labor & Delivery. Her Biodesign "externship" was carried out at Onset Ventures in Menlo Park where she performed market, technical, and clinical diligence on potential medical device investments. She is also a member of the Stanford Biodesign Alumni Association Board.